MXPA03006218A - Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo. - Google Patents
Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.Info
- Publication number
- MXPA03006218A MXPA03006218A MXPA03006218A MXPA03006218A MXPA03006218A MX PA03006218 A MXPA03006218 A MX PA03006218A MX PA03006218 A MXPA03006218 A MX PA03006218A MX PA03006218 A MXPA03006218 A MX PA03006218A MX PA03006218 A MXPA03006218 A MX PA03006218A
- Authority
- MX
- Mexico
- Prior art keywords
- crf2
- ctokine
- receptor
- type
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invencion proporciona polinucleotidos y polipeptidos CRF2-12 aislados, novedosos, codificados por polinucleotidos CRF2-12. Tambien se proporcionan los anticuerpos que se unen inmunoespecificamente a un polipeptido CRF2-12 o a cualquier derivado (incluyendo un derivado de fusion), variante, mutante del polipeptido, polinucle6tido o anticuerpo de CRF2-12. La invencion proporciona ademas, metodos en los cuales un polipeptido, polinucle6tido y anticuerpo CRFS-12, se utilizan en la deteccion y tratamiento de una amplia gama de estados patologicos, asi como para otros usos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26144201P | 2001-01-12 | 2001-01-12 | |
US26702101P | 2001-02-06 | 2001-02-06 | |
US27083501P | 2001-02-23 | 2001-02-23 | |
PCT/US2002/000986 WO2002066647A2 (en) | 2001-01-12 | 2002-01-14 | Type 2 ctokine receptor and nucleic acids encoding same |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03006218A true MXPA03006218A (es) | 2004-09-13 |
Family
ID=27401407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03006218A MXPA03006218A (es) | 2001-01-12 | 2002-01-14 | Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo. |
Country Status (8)
Country | Link |
---|---|
US (2) | US7176180B2 (es) |
EP (1) | EP1404831A2 (es) |
JP (2) | JP2004533811A (es) |
AU (1) | AU2002249948B2 (es) |
CA (1) | CA2434652A1 (es) |
MX (1) | MXPA03006218A (es) |
NZ (1) | NZ527087A (es) |
WO (1) | WO2002066647A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6939545B2 (en) * | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
EP1234035B1 (en) | 1999-12-03 | 2010-02-24 | ZymoGenetics, Inc. | Human cytokine receptor |
US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
US6740520B2 (en) * | 2000-03-21 | 2004-05-25 | Genentech, Inc. | Cytokine receptor and nucleic acids encoding the same |
US20040086970A1 (en) * | 2000-03-22 | 2004-05-06 | Genentech, Inc. | Novel cytokine receptors and nucleic acids encoding the same |
ATE547525T1 (de) | 2000-08-08 | 2012-03-15 | Zymogenetics Inc | Lösliche zcyctor 11 cytokinrezeptoren |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US7094570B2 (en) | 2003-03-11 | 2006-08-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
WO2002070655A2 (en) | 2001-03-02 | 2002-09-12 | Zymogenetics, Inc. | Mouse cytokine receptor |
US20030099608A1 (en) | 2001-03-27 | 2003-05-29 | Presnell Scott R. | Human cytokine receptor |
US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
EP1606316A2 (en) | 2003-03-24 | 2005-12-21 | ZymoGenetics, Inc. | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
WO2006047249A1 (en) | 2004-10-22 | 2006-05-04 | Zymogenetics, Inc. | Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
AU2006342792A1 (en) | 2005-12-02 | 2007-11-08 | Genentech, Inc. | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to IL-22 and IL-22R |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5319071A (en) * | 1987-11-25 | 1994-06-07 | Immunex Corporation | Soluble interleukin-1 receptors |
AU1919201A (en) * | 1999-11-18 | 2001-05-30 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
EP1234035B1 (en) | 1999-12-03 | 2010-02-24 | ZymoGenetics, Inc. | Human cytokine receptor |
AU2292601A (en) | 1999-12-23 | 2001-07-03 | Zymogenetics Inc. | Novel cytokine zcyto18 |
AU2001255168A1 (en) | 2000-03-03 | 2001-09-17 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
US6740520B2 (en) * | 2000-03-21 | 2004-05-25 | Genentech, Inc. | Cytokine receptor and nucleic acids encoding the same |
NZ523122A (en) | 2000-06-22 | 2004-06-25 | Smithkline Beecham Corp | Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases |
US20030219862A1 (en) * | 2001-06-22 | 2003-11-27 | Pankaj Agarwal | Novel compounds |
ATE547525T1 (de) | 2000-08-08 | 2012-03-15 | Zymogenetics Inc | Lösliche zcyctor 11 cytokinrezeptoren |
CA2632702A1 (en) | 2000-09-01 | 2002-03-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US20030022827A1 (en) | 2000-09-25 | 2003-01-30 | Bertram Weiss | Three new members of the cytokine receptor family class 2 |
EP1191035A3 (de) * | 2000-09-25 | 2002-04-17 | Schering Aktiengesellschaft | Drei Mitglieder der Zytokinrezeptorfamilie Klasse II |
WO2002070655A2 (en) * | 2001-03-02 | 2002-09-12 | Zymogenetics, Inc. | Mouse cytokine receptor |
-
2002
- 2002-01-14 MX MXPA03006218A patent/MXPA03006218A/es unknown
- 2002-01-14 JP JP2002566352A patent/JP2004533811A/ja active Pending
- 2002-01-14 EP EP02718833A patent/EP1404831A2/en not_active Withdrawn
- 2002-01-14 NZ NZ527087A patent/NZ527087A/en unknown
- 2002-01-14 WO PCT/US2002/000986 patent/WO2002066647A2/en active Application Filing
- 2002-01-14 AU AU2002249948A patent/AU2002249948B2/en not_active Ceased
- 2002-01-14 US US10/047,264 patent/US7176180B2/en not_active Expired - Fee Related
- 2002-01-14 CA CA002434652A patent/CA2434652A1/en not_active Withdrawn
-
2007
- 2007-01-11 US US11/652,099 patent/US20070196370A1/en not_active Abandoned
-
2008
- 2008-04-16 JP JP2008107333A patent/JP2008188023A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002066647A2 (en) | 2002-08-29 |
JP2004533811A (ja) | 2004-11-11 |
WO2002066647A3 (en) | 2004-02-12 |
JP2008188023A (ja) | 2008-08-21 |
AU2002249948B2 (en) | 2007-08-23 |
CA2434652A1 (en) | 2002-08-29 |
US20070196370A1 (en) | 2007-08-23 |
US20030170839A1 (en) | 2003-09-11 |
EP1404831A2 (en) | 2004-04-07 |
NZ527087A (en) | 2008-09-26 |
US7176180B2 (en) | 2007-02-13 |
AU2002249948B9 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000058473A3 (en) | Nucleic acids including open reading frames encoding polypeptides; 'orfx' | |
WO2001092523A3 (en) | Human polynucleotides and polypeptides encoded thereby | |
WO2001007595A3 (en) | Novel fibroblast growth factor and nucleic acids encoding same | |
MXPA03006218A (es) | Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo. | |
WO2004048521A3 (en) | Composition and method for treating lupus nephritis | |
WO2001036645A3 (en) | Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same | |
WO2000053742A3 (en) | Polynucleotides and proteins encoded thereby | |
WO2001049729A3 (en) | Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use | |
WO2001074856A3 (en) | Wnt-7b-like polypeptides and nucleic acids encoding same | |
WO2001062928A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001070978A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2002002625A3 (en) | Novel fibroblast growth factors and nucleic acids encoding same | |
WO2001061009A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2003025147A3 (en) | Novel polynucleotides and proteins encoded thereby | |
WO2001044473A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001036638A8 (en) | Polypeptides and nucleic acids encoding same | |
WO2003040345A3 (en) | Type 2 cytokine receptor and nucleic acids encoding same | |
WO2000061754A3 (en) | Human proteins and polynucleotides encoding them | |
WO2001023561A3 (en) | Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats | |
WO2001068851A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2000070046A3 (en) | Secreted polypeptides and corresponding polynucleotides | |
WO2001032874A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001023572A3 (en) | Polynucleotides and polypeptides encoded thereby | |
WO2000075321A3 (en) | Polynucleotides and membrane-bound polypeptide encoded thereby | |
WO2001051632A3 (en) | Odorant receptor polypeptides and nucleic acids encoding same |